The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Pnv-Dha
ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent · ASCORBIC ACID 28 mg/1; CALCIUM 160 mg/1; FERROUS FUMARATE 27 mg/1; CHOLECALCIFEROL 400 [iU]/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 30 [iU]/1; PYRIDOXINE 25 mg/1; FOLIC ACID 1.25 mg/1; DOCONEXENT 300 mg/1 · Capsule, Gelatin Coated · Oral · Acella Pharmaceuticals, LLC
NDC 42192-0323-30 · 30 CAPSULE, GELATIN COATED in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
Medicaid spend (2023)
$752
14 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Acella Pharmaceuticals, LLCUnited Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine, folic acid, calcium, ferrous fumarate, doconexent (Capsule, Gelatin Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | ASCORBIC ACID 28 mg/1; CALCIUM 160 mg/1; FERROUS FUMARATE 27 mg/1; CHOLECALCIFEROL 400 [iU]/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 30 [iU]/1; PYRIDOXINE 25 mg/1; FOLIC ACID 1.25 mg/1; DOCONEXENT 300 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Acella Pharmaceuticals, LLC | ASCORBIC ACID 30 [iU]/1; CALCIUM 28 mg/1; FERROUS FUMARATE 160 mg/1; CHOLECALCIFEROL 400 [iU]/1; .ALPHA.-TOCOPHEROL ACETATE, DL- 300 mg/1; PYRIDOXINE 27 mg/1; FOLIC ACID 1.25 mg/1; DOCONEXENT 25 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Acella Pharmaceuticals, LLC | .ALPHA.-TOCOPHEROL ACETATE, DL- 30 [iU]/1; ASCORBIC ACID 28 mg/1; CALCIUM 160 mg/1; CHOLECALCIFEROL 400 [iU]/1; DOCONEXENT 300 mg/1; FERROUS FUMARATE 27 mg/1; FOLIC ACID 1.25 mg/1; PYRIDOXINE 25 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Pnv-Dha — NDC 42192-0323-30," retrieved September 3, 2026, https://drugdashboards.com/drug/42192032330.
Free to cite with attribution — see how the data is put together.